Thermo Fisher Scientific | TMO - Sales Revenues


Thermo Fisher Scientific reported $11.01B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Agilent USD 1.84B 37M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Bio Techne USD 311.4M 15.5M Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
Boston Scientific USD 5.2B 90M Mar/2026
Bruker USD 823.4M 153.8M Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 880M 81M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
General Electric Aerospace USD 11.6B 270M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Illumina USD 1.09B 70M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
Laboratory Of America USD 3.54B 20M Mar/2026
Medtronic USD 9.8B 800M Mar/2026
Mettler Toledo International USD 947.13M 182.87M Mar/2026
Myriad Genetics USD 200.4M 9.4M Mar/2026
Olympus JPY 295.28B 34.23B Mar/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Repligen USD 194M 3.91M Mar/2026
Revvity USD 711M 61.06M Mar/2026
Stryker USD 6B 1.2B Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Veracyte USD 139.07M 1.53M Mar/2026
Waters USD 1.27B 338M Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026